Trial intelligence / Profile preview

Topiramate in Problem Gamblers

NCT00370188Phase 2Withdrawn

Sponsor
Center for Addiction and Mental Health
Start
Sep 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in gambling disorder (GD) comparing Topiramate with Placebo (2 arms). Primary endpoints: Yale-Brown Obsessive Compulsive Scale and Canadian Problem Gambling Index. Planned start Sep 2006; status: withdrawn.

02

Drugs

topiramate
03

Conditions

gambling disorder (GD)

Beyond the preview

Go deeper on NCT00370188.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00370188.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call